Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Submitted by
admin
on August 26, 2013 - 9:33am
Source:
Fierce Biotech
News Tags:
Actelion
FDA
Ceptaris
Valchlor
cutaneous T-cell lymphoma
Headline:
Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Do Not Allow Advertisers to Use My Personal information
